N-[5-[4-[1-(7-fluoro-2,3-dihydro-[1,4]dioxino[2,3-b]pyridin-6-yl)ethyl]piperazin-1-yl]-1,3,4-thiadiazol-2-yl]acetamide
C17H21FN6O3S — CID 156524471
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[5-[4-[1-(7-fluoro-2,3-dihydro-[1,4]dioxino[2,3-b]pyridin-6-yl)ethyl]piperazin-1-yl]-1,3,4-thiadiazol-2-yl]acetamide
N-[5-[4-[1-(7-fluoro-2,3-dihydro-[1,4]dioxino[2,3-b]pyridin-6-yl)ethyl]piperazin-1-yl]-1,3,4-thiadiazol-2-yl]acetamide (PubChem CID 156524471) has the molecular formula C17H21FN6O3S and a molecular weight of 408.46 g/mol. Its IUPAC name is N-[5-[4-[1-(7-fluoro-2,3-dihydro-[1,4]dioxino[2,3-b]pyridin-6-yl)ethyl]piperazin-1-yl]-1,3,4-thiadiazol-2-yl]acetamide.
Molecular Properties
| Compound Name | N-[5-[4-[1-(7-fluoro-2,3-dihydro-[1,4]dioxino[2,3-b]pyridin-6-yl)ethyl]piperazin-1-yl]-1,3,4-thiadiazol-2-yl]acetamide |
|---|---|
| PubChem CID | 156524471 |
| Molecular Formula | C17H21FN6O3S |
| Molecular Weight | 408.46 g/mol |
| Exact Mass | 408.14 |
| IUPAC Name | N-[5-[4-[1-(7-fluoro-2,3-dihydro-[1,4]dioxino[2,3-b]pyridin-6-yl)ethyl]piperazin-1-yl]-1,3,4-thiadiazol-2-yl]acetamide |
| SMILES | CC(=O)Nc1nnc(N2CCN(C(C)c3nc4c(cc3F)OCCO4)CC2)s1 |
| InChI | InChI=1S/C17H21FN6O3S/c1-10(14-12(18)9-13-15(20-14)27-8-7-26-13)23-3-5-24(6-4-23)17-22-21-16(28-17)19-11(2)25/h9-10H,3-8H2,1-2H3,(H,19,21,25) |
| InChIKey | XCGWOQMMKNILIZ-UHFFFAOYSA-N |
| XLogP | 1.68 |
| TPSA | 92.71 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 408.46 |
| LogP ≤ 5 | 1.68 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156524471 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.